Alira Health

Alira Health

Alira Health Partners with Policy Matters to Foster Market Access in the UK

The partnership strengthens the company’s global consulting services throughout its presence in Northern Europe.

Published on:
November 15, 2022

Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announces its partnership with leading UK market access specialist consultancy Policy Matters. Policy Matters is an independent consultancy offering end-to-end market access solutions. The Alira Health and Policy Matters partnership allows Alira Health to reach clients based in the UK through dedicated regional projects while fostering the company’s global market access solutions through the expertise of one of the most experienced local access companies in the UK.

It is an honour for us to join forces with Policy Matters, a cooperation that further expands our global reach. Policy Matters has an over twenty-year reputation for securing funding for some of the most innovative treatments now available on the NHS, as well as providing decades long support to industry collectives and organisations. This means that our clients will benefit from the expertise of the very senior and highly skilled team of Policy Matters UK specialists, while having seamless access to the array of Alira Health services we offer including strategic consulting and tailored solutions.
Nerea Blanqué-Catalina Senior Vice President Global Market Access at Alira Health
In the post-Brexit world our clients need a team that knows the UK intimately - regulatory, access routes and pricing, that is able to ensure reimbursement is successfully secured, while being cognisant of the impact of the UK on European and other markets and vice versa. The UK market is increasingly complex and challenging. Over the years we have worked alongside several HEOR and pricing consultancies but have finally found one that perfectly complements our offering.
Beverley Evans Partner at Policy Matters
About Alira Health

Alira Health is a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, in partnership with patients, through innovative technologies and expert guidance. From development to medical care, Alira Health complements the expertise of its Pharma, Biotech, and MedTech clients with a full spectrum of services across their entire solutions lifecycle.

Learn more:

About Policy Matters

Policy Matters is an independent UK based market access and healthcare policy consultancy offering dynamic and effective bespoke, integrated access strategies, based on their exceptional understanding of the constantly evolving UK healthcare and access environment. They focus on companies that develop and supply medicines, technologies, devices, and services to UK National Health Service (NHS) organizations.

Learn more:

Related news

Events April 24, 2024
MGFA National Patient Conference 2024
We are pleased to share that we will be participating in MGFA National Patient Conference 2024 as speakers and exhibitors.
Digital Health Innovation Myasthenia Gravis (MG) Patient Engagement Rare Disease
Articles March 18, 2024
WHO Model Lists of Essential Medicines: What You Need to Know 
Our Market Access experts share the importance of the EML for pharma companies and four best practices for a successful application, based on our extensive experience in interactions with the WHO.
Market Access
Events February 20, 2024
World EPA Congress Europe
Look for market access and pricing experts Ahmad Bechara and Andrea Mantovani representing Alira Health on the agenda at World EPA Congress.
Market Access Pricing Real-World Evidence (RWE)
News January 24, 2024
Alira Health and AseBio Announce Market Access Mentoring Program for 2024
Alira Health and AseBio, the Spanish Bioindustry Association, are pleased to announce the 2024 edition of their market access mentoring program for AseBio members.
Biotech Market Access Spain Startups
Case Studies January 18, 2024
Pharma Company Succeeds in Adding Medicine to World Health Organization Essential Medicines List
A pharma company with a blood disorder treatment needed support to submit a value dossier to the WHO to add a medicine to the Essential Medicines List.
Market Access Pharma
News January 18, 2024
Alira Health and Biocat Announce Startup Support Program for 2024
Alira Health and Biocat, a strategic stakeholder building the Catalan life sciences and ecosystem, partnered to foster Market Access for startups.
Market Access Startups
Events January 17, 2024
Presentation: Pilot Project for the Inclusion of the Patient Voices in the Regional Market Access Drug Committees in Spain
On January 23rd we will present the results of the first phase of the “Pilot Project for the Inclusion of the Patient Voices in the Regional Market Access Drug Committees in Spain.”
Market Access Patient Engagement Spain
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.